BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4035697)

  • 1. A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats.
    Aas P; Sterri SH; Hjermstad HP; Fonnum F
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):437-45. PubMed ID: 4035697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
    Jokanović M
    Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation apparatus for generating sarin and soman toxic vapors.
    Sevelová L; Vachek J; Bajgar J
    Acta Medica (Hradec Kralove); 2003; 46(4):157-61. PubMed ID: 14965166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toxic effect of an AChE-inhibitor on the cholinergic nervous system in airway smooth muscle.
    Aas P
    Toxicology; 1988 Apr; 49(1):91-7. PubMed ID: 3376127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
    Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes.
    Fonnum F; Sterri SH; Aas P; Johnsen H
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S29-38. PubMed ID: 4092894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of soman on bronchial smooth muscle.
    Aas P; Veiteberg T; Fonnum F
    Biochem Pharmacol; 1986 Jun; 35(11):1793-9. PubMed ID: 3718528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aliesterase in organophosphate poisoning.
    Clement JG
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats.
    Maxwell DM; Lenz DE; Groff WA; Kaminskis A; Froehlich HL
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):66-76. PubMed ID: 3564032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of serine esterases in different rat tissues following inhalation of soman.
    Walday P; Aas P; Fonnum F
    Biochem Pharmacol; 1991 Jan; 41(1):151-3. PubMed ID: 1986740
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
    Carrington CD; Abou-Donia MB
    J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esterase activities and soman toxicity in developing rat.
    Sterri SH; Berge G; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):136-40. PubMed ID: 4061089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy.
    Perkins MW; Wong B; Rodriguez A; Devorak JL; Alves DA; Murphy G; Sciuto AM
    Chem Biol Interact; 2013 Dec; 206(3):452-61. PubMed ID: 23886498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs.
    Benschop HP; Trap HC; Spruit HE; Van Der Wiel HJ; Langenberg JP; De Jong LP
    Toxicol Appl Pharmacol; 1998 Dec; 153(2):179-85. PubMed ID: 9878589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
    Clement JG; Erhardt N
    Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.
    Dabisch PA; Horsmon MS; Muse WT; Mioduszewski RJ; Thomson S
    Toxicol Sci; 2007 Nov; 100(1):281-9. PubMed ID: 17693423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM; Brecht KM; O'Neill BL
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.